Examining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach

by Alten, Rieke, Krüger, Klaus, Rellecke, Julian, Schiffner-Rohe, Julia, Behmer, Olaf, Schiffhorst, Guido, Nolting, Hans-Dieter
Published 2016

Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis

by Alten, Rieke, Grahn, Amy, Holt, Robert J, Rice, Patricia, Buttgereit, Frank
Published 2015

Long-Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment

by Alten, Rieke, Kaine, Jeffrey, Keystone, Edward, Nash, Peter, Delaet, Ingrid, Genovese, Mark C
Published 2014

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept

by Alten, Rieke, Bingham, Clifton O., Cohen, Stanley B., Curtis, Jeffrey R., Kelly, Sheila, Wong, Dennis, Genovese, Mark C.
Published 2016

Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study

by Alten, Rieke, Gomez-Reino, Juan, Durez, Patrick, Beaulieu, Andre, Sebba, Anthony, Krammer, Gerhard, Preiss, Ralph, Arulmani, Udayasankar, Widmer, Albert, Gitton, Xavier, Kellner, Herbert
Published 2011

Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)

by Buttgereit, Frank, Mehta, Daksha, Kirwan, John, Szechinski, Jacek, Boers, Maarten, Alten, Rieke E, Supronik, Jerzy, Szombati, Istvan, Romer, Ulrike, Witte, Stephan, Saag, Kenneth G
Published 2013

Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial

by Strand, Vibeke, Lee, Eun Bong, Fleischmann, Roy, Alten, Rieke E, Koncz, Tamas, Zwillich, Samuel H, Gruben, David, Wilkinson, Bethanie, Krishnaswami, Sriram, Wallenstein, Gene
Published 2016

Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

by Baraliakos, Xenofon, Listing, Joachim, Brandt, Jan, Zink, Angela, Alten, Rieke, Burmester, Gerd, Gromnica-Ihle, Erika, Kellner, Herbert, Schneider, Matthias, Sörensen, Helmut, Zeidler, Hennig, Rudwaleit, Martin, Sieper, Joachim, Braun, Juergen
Published 2005

Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective...

by Nüßlein, Hubert G, Alten, Rieke, Galeazzi, Mauro, Lorenz, Hanns-Martin, Boumpas, Dimitrios, Nurmohamed, Michael T, Bensen, William G, Burmester, Gerd R, Peter, Hans-Hartmut, Rainer, Franz, Pavelka, Karel, Chartier, Melanie, Poncet, Coralie, Rauch, Christiane, Bars, Manuela Le
Published 2014

Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised...

by Conaghan, Philip G, Durez, Patrick, Alten, Rieke E, Burmester, Gerd-Rüdiger, Tak, Paul P, Klareskog, Lars, Catrina, Anca Irinel, DiCarlo, Julie, Gaillez, Corine, Le Bars, Manuela, Zhou, Xianhuang, Peterfy, Charles
Published 2013

Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

by Nüßlein, Hubert G., Alten, Rieke, Galeazzi, Mauro, Lorenz, Hanns-Martin, Nurmohamed, Michael T., Bensen, William G., Burmester, Gerd R., Peter, Hans-Hartmut, Pavelka, Karel, Chartier, Melanie, Poncet, Coralie, Rauch, Christiane, Le Bars, Manuela
Published 2015

Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools

by van Riel, Piet, Alten, Rieke, Combe, Bernard, Abdulganieva, Diana, Bousquet, Paola, Courtenay, Molly, Curiale, Cinzia, Gómez-Centeno, Antonio, Haugeberg, Glenn, Leeb, Burkhard, Puolakka, Kari, Ravelli, Angelo, Rintelen, Bernhard, Sarzi-Puttini, Piercarlo
Published 2016

Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study

by Alten, Rieke, Nüßlein, Hubert, Galeazzi, Mauro, Lorenz, Hanns-Martin, Nurmohamed, Michael T, Bensen, William G, Burmester, Gerd R, Peter, Hans-Hartmut, Pavelka, Karel, Chartier, Mélanie, Poncet, Coralie, Rauch, Christiane, Elbez, Yedid, Le Bars, Manuela
Published 2016

Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis

by Preuße, Corinna, Allenbach, Yves, Hoffmann, Olaf, Goebel, Hans-Hilmar, Pehl, Debora, Radke, Josefine, Doeser, Alexandra, Schneider, Udo, Alten, Rieke H.E., Kallinich, Tilmann, Benveniste, Olivier, von Moers, Arpad, Schoser, Benedikt, Schara, Ulrike, Stenzel, Werner
Published 2016

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment

by Rech, Juergen, Hueber, Axel J, Finzel, Stephanie, Englbrecht, Matthias, Haschka, Judith, Manger, Bernhard, Kleyer, Arnd, Reiser, Michaela, Cobra, Jayme Fogagnolo, Figueiredo, Camille, Tony, Hans-Peter, Kleinert, Stefan, Wendler, Joerg, Schuch, Florian, Ronneberger, Monika, Feuchtenberger, Martin, Fleck, Martin, Manger, Karin, Ochs, Wolfgang, Schmitt-Haendle, Matthias, Lorenz, Hanns-Martin, Nuesslein, Hubert, Alten, Rieke, Henes, Joerg, Krueger, Klaus, Schett, Georg
Published 2016

Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set

by Bykerk, Vivian P, Bingham, Clifton O, Choy, Ernest H, Lin, Daming, Alten, Rieke, Christensen, Robin, Furst, Daniel E, Hewlett, Sarah, Leong, Amye, March, Lyn, Woodworth, Thasia, Boire, Gilles, Haraoui, Boulos, Hitchon, Carol, Jamal, Shahin, Keystone, Edward C, Pope, Janet, Tin, Diane, Thorne, J Carter, Bartlett, Susan J
Published 2016